STUDIES OF ALPHA-DEFENSINS IN PRIMATE INNATE IMMUNITY

灵长类先天免疫中阿尔法防御素的研究

基本信息

  • 批准号:
    7144774
  • 负责人:
  • 金额:
    $ 36.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-07-01 至 2011-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The purpose of this research is to investigate the role of alpha-defensins in innate immunity of the rhesus macaque (Macaca mulatta). The goals of the proposed studies are to define the determinants of primate alpha-defensin bactericidal activity, their mechanisms of action, and to characterize mechanisms that regulate myeloid (RMADs) and Paneth cell (REDs) alpha-defensin biosynthesis at the transcriptional and posttranslational levels. We propose to quantitate the expression of RED and RMAD mRNAs and peptides in small bowel mucosa, neutrophils and NK cells, characterize and compare their mechanisms of action and the structural basis of that activity, investigate mechanisms of proRED and proRMAD activation in Paneth cells and myeloid cells, and identify cis-acting structural components of RMAD and RED genes that regulate the specificity of their transcription. In Aim #1, the microbicidal activities of REDs 1-6 will be tested against varied bacterial species, and membrane disruptive activities of natural and mutant REDs and RMADs will be characterized and quantitated. The hypothesis that mutagenesis alters peptide structure will be tested by determining NMR structures of native and mutant RED4 and RMAD4 peptides in solution and in the presence of rapidly-tumbling phospholipid bicelles to test the hypothesis that specific residue positions interact with phospholipid bilayers. In Aim #2, we will test the hypothesis that alpha-defensin precursor processing is mediated by lineage-specific proteolytic events by measuring the extent of RED and RMAD precursor processing in intact monkey small intestine and in rhesus neutrophils, NK cells, and monocytes. We will identify the respective processing enzymes, determine whether precursor proteolysis is coincident with activation of bactericidal activity, and determine the effect of mutations at conserved alpha-defensin positions on peptide folding, disulfide bond formation, activation, and membrane binding and disruption. Thus, in Aim #3, the hypotheses that primate alpha-defensin gene expression is regulated by lineage-specific, cis-acting elements will be tested by quantitating the expression and distribution of individual RED and RMAD mRNAs in enteric and myeloid tissues and by identifying determinants of lineage-specific alpha-defensin gene transcription. Potential lineage-specific gene regulatory regions will be assayed by functional analyses of RED and RMAD promoter constructs and chimeric minigenes in cultured monocytes.
描述(由申请人提供):本研究的目的是研究α-防御素在恒河猴(Macaca mulatta)先天免疫中的作用。拟议研究的目标是确定灵长类动物α-防御素杀菌活性的决定因素,其作用机制,并表征在转录和翻译后水平调节髓样(RMADs)和潘氏细胞(RED)α-防御素生物合成的机制。我们建议定量表达RED和RMAD mRNA和肽在小肠粘膜,中性粒细胞和NK细胞,表征和比较其作用机制和活性的结构基础,研究潘氏细胞和骨髓细胞中的proRED和proRMAD激活机制,并确定调节其转录特异性的RMAD和RED基因的顺式作用结构成分。在目标#1中,将测试RED 1-6对不同细菌物种的杀微生物活性,并将表征和定量天然和突变RED和RMAD的膜破坏活性。诱变改变肽结构的假设将通过测定溶液中天然和突变体RED 4和RMAD 4肽的NMR结构以及存在快速翻滚的磷脂双胞来测试,以测试特定残基位置与磷脂双分子层相互作用的假设。在目标#2中,我们将通过测量完整猴小肠和恒河猴中性粒细胞、NK细胞和单核细胞中RED和RMAD前体加工的程度来检验α-防御素前体加工由谱系特异性蛋白水解事件介导的假设。我们将确定各自的加工酶,确定前体蛋白水解是否与杀菌活性的激活相一致,并确定保守的α-防御素位置突变对肽折叠,二硫键形成,激活和膜结合和破坏的影响。因此,在目标#3中,灵长类动物α-防御素基因表达受谱系特异性顺式作用元件调节的假设将通过定量肠和骨髓组织中单个RED和RMAD mRNA的表达和分布以及通过鉴定谱系特异性α-防御素基因转录的决定簇来测试。通过对培养的单核细胞中RED和RMAD启动子构建体和嵌合小基因进行功能分析,测定潜在的谱系特异性基因调控区。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Andre J. Ouellette其他文献

Mouse paneth cell secretory responses to <em>in vitro</em> microbial infection
  • DOI:
    10.1016/s0016-5085(00)84911-2
  • 发表时间:
    2000-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Tokiyoshi Ayabe;Donald P. Satchell;Carole L. Wilson;William C. Parks;Michael E. Selsted;Andre J. Ouellette
  • 通讯作者:
    Andre J. Ouellette
The calcium-activated potassium channel, <em>mIKCa1</em>, is paneth cell-specific in mouse small intestinal epithelium and functions in the secretory response
  • DOI:
    10.1016/s0016-5085(00)82463-4
  • 发表时间:
    2000-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Tokiyoshi Ayabe;Sanjiv Ghanshani;K. George Chandy;Dalila Darmoul;Andre J. Ouellette
  • 通讯作者:
    Andre J. Ouellette

Andre J. Ouellette的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Andre J. Ouellette', 18)}}的其他基金

Host defense-stimulating macrocyclic peptides for treatment of MDR bacterial infections
用于治疗耐多药细菌感染的宿主防御刺激大环肽
  • 批准号:
    9145465
  • 财政年份:
    2016
  • 资助金额:
    $ 36.23万
  • 项目类别:
Host defense-stimulating macrocyclic peptides for treatment of MDR bacterial infections
用于治疗耐多药细菌感染的宿主防御刺激大环肽
  • 批准号:
    9267426
  • 财政年份:
    2016
  • 资助金额:
    $ 36.23万
  • 项目类别:
Host defense-stimulating macrocyclic peptides for treatment of MDR bacterial infections
用于治疗耐多药细菌感染的宿主防御刺激大环肽
  • 批准号:
    9912709
  • 财政年份:
    2016
  • 资助金额:
    $ 36.23万
  • 项目类别:
Innate enteric immunity during induced Paneth cell deficiency
诱导潘氏细胞缺陷期间的先天肠道免疫
  • 批准号:
    8493004
  • 财政年份:
    2013
  • 资助金额:
    $ 36.23万
  • 项目类别:
FRET ON MOUSE PRO-ALPHA-DEFENSIN
小鼠阿尔法防御素原的烦恼
  • 批准号:
    8170954
  • 财政年份:
    2010
  • 资助金额:
    $ 36.23万
  • 项目类别:
FRET ON MOUSE PRO-ALPHA-DEFENSIN
小鼠阿尔法防御素原的烦恼
  • 批准号:
    7956510
  • 财政年份:
    2009
  • 资助金额:
    $ 36.23万
  • 项目类别:
STUDIES OF ALPHA-DEFENSINS IN PRIMATE INNATE IMMUNITY
灵长类先天免疫中阿尔法防御素的研究
  • 批准号:
    7456535
  • 财政年份:
    2006
  • 资助金额:
    $ 36.23万
  • 项目类别:
STUDIES OF ALPHA-DEFENSINS IN PRIMATE INNATE IMMUNITY
灵长类先天免疫中阿尔法防御素的研究
  • 批准号:
    7640893
  • 财政年份:
    2006
  • 资助金额:
    $ 36.23万
  • 项目类别:
STUDIES OF ALPHA-DEFENSINS IN PRIMATE INNATE IMMUNITY
灵长类先天免疫中阿尔法防御素的研究
  • 批准号:
    7900547
  • 财政年份:
    2006
  • 资助金额:
    $ 36.23万
  • 项目类别:
STUDIES OF ALPHA-DEFENSINS IN PRIMATE INNATE IMMUNITY
灵长类先天免疫中阿尔法防御素的研究
  • 批准号:
    7250290
  • 财政年份:
    2006
  • 资助金额:
    $ 36.23万
  • 项目类别:

相似海外基金

Control by Beta 7 integrins of the bacterial triggers of IBD
Beta 7 整合素控制 IBD 细菌触发因素
  • 批准号:
    10481726
  • 财政年份:
    2023
  • 资助金额:
    $ 36.23万
  • 项目类别:
Development of a RIG-I agonist RNA as a cure for chronic Hepatitis B
开发 RIG-I 激动剂 RNA 来治疗慢性乙型肝炎
  • 批准号:
    10699796
  • 财政年份:
    2023
  • 资助金额:
    $ 36.23万
  • 项目类别:
Immune function of bitter taste receptors in human macrophages
人巨噬细胞苦味受体的免疫功能
  • 批准号:
    10418464
  • 财政年份:
    2022
  • 资助金额:
    $ 36.23万
  • 项目类别:
Establishing and Implementing Pneumonia Diagnosis in ED Older Adults: A Mixed Methods Approach
在急诊科老年人中建立和实施肺炎诊断:混合方法
  • 批准号:
    10513959
  • 财政年份:
    2022
  • 资助金额:
    $ 36.23万
  • 项目类别:
Dynamics of HIV-infection, Oral Innate Immunity and The Development of Oral Diseases in Children
HIV感染动态、口腔先天免疫和儿童口腔疾病的发展
  • 批准号:
    10534585
  • 财政年份:
    2022
  • 资助金额:
    $ 36.23万
  • 项目类别:
Dynamics of HIV-infection, Oral Innate Immunity and The Development of Oral Diseases in Children
HIV感染动态、口腔先天免疫和儿童口腔疾病的发展
  • 批准号:
    10653227
  • 财政年份:
    2022
  • 资助金额:
    $ 36.23万
  • 项目类别:
Radiation-Induced Paneth Cell Dysfunction
辐射引起的潘氏细胞功能障碍
  • 批准号:
    10474225
  • 财政年份:
    2022
  • 资助金额:
    $ 36.23万
  • 项目类别:
Immune function of bitter taste receptors in human macrophages
人巨噬细胞苦味受体的免疫功能
  • 批准号:
    10555248
  • 财政年份:
    2022
  • 资助金额:
    $ 36.23万
  • 项目类别:
Radiation-Induced Paneth Cell Dysfunction
辐射引起的潘氏细胞功能障碍
  • 批准号:
    10686031
  • 财政年份:
    2022
  • 资助金额:
    $ 36.23万
  • 项目类别:
Establishing and Implementing Pneumonia Diagnosis in ED Older Adults: A Mixed Methods Approach
在急诊科老年人中建立和实施肺炎诊断:混合方法
  • 批准号:
    10705136
  • 财政年份:
    2022
  • 资助金额:
    $ 36.23万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了